New 1-(2-chloroquinolin-3-yl)-4-dimethylamino-2-(naphthalen-1-yl)-1-phenylbutan-2-ols with antituberculosis activity
- Авторы: Omel’kov A.V.1, Fedorov V.E.1, Stepanov A.A.1
-
Учреждения:
- Pharm-Sintez
- Выпуск: Том 68, № 10 (2019)
- Страницы: 1908-1918
- Раздел: Full Articles
- URL: https://journals.rcsi.science/1066-5285/article/view/243507
- DOI: https://doi.org/10.1007/s11172-019-2646-5
- ID: 243507
Цитировать
Аннотация
New 4-dimethylamino-2-(naphthalen-1-yl)-1-phenyl-1-(quinolin-3-yl)butan-2-ols with antituberculosis activity were synthesized. (1R*,2S*)-1-(6-Bromo-2-chloroquinolin-3-yl)-4-dimethylamino-2-(naphthalen-1-yl)-1-phenylbutan-2-ol hydrocitrate exhibiting high antituberculosis activity is in the final stage of clinical trials and is prepared for use in clinical practice.
Об авторах
A. Omel’kov
Pharm-Sintez
Автор, ответственный за переписку.
Email: omelkov@mail.ru
Россия, Build. 134, 29 ul. Vereyskaya, Moscow, 121357
V. Fedorov
Pharm-Sintez
Email: omelkov@mail.ru
Россия, Build. 134, 29 ul. Vereyskaya, Moscow, 121357
A. Stepanov
Pharm-Sintez
Email: omelkov@mail.ru
Россия, Build. 134, 29 ul. Vereyskaya, Moscow, 121357
Дополнительные файлы
